A Multicenter Controlled Open-label Trial of Evaluating Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate and Entecavir in Acute-on-chronic Liver Failure of Chronic Hepatitis B Patients
Phase of Trial: Phase IV
Latest Information Update: 08 May 2019
Price : $35 *
At a glance
- Drugs Entecavir (Primary) ; Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 02 May 2019 Planned End Date changed from 1 Mar 2025 to 1 Jul 2022.
- 02 May 2019 Planned primary completion date changed from 1 Mar 2024 to 1 Apr 2021.
- 02 May 2019 Status changed from not yet recruiting to recruiting.